Health IT · on the rundown Tuesday, April 21, 2026
Hong Kong signs 22 strategic enterprises under OASES scheme
Covered by 1 outlet. First reported by scmp.com at 01:30 UTC on April 21, 2026.
- outlets1
- distinct reports1
- first to latest report0 h
- names in it5
What happened?
- The latest group is the sixth cohort under the initiative since its 2022 launch, bringing total strategic partners to more than 120, the report said.
- The cohort includes Pfizer, Amgen, Boehringer Ingelheim, Jiangsu Hengrui Pharmaceuticals, HAYA Therapeutics, DiDi, AutoFlight and LightSpeed Studios, according to the report.
The cohort is the sixth under the government initiative launched in 2022, bringing total strategic partners to more than 120, the report said.
A machine summary written from the reports listed below; read them for the full account. How summaries are made and what is checked.
Who reported it, and when?
| Time | Report | Run by |
|---|---|---|
| Apr 21 01:30 | Which global firms are being attracted by Hong Kong’s strategic enterprise scheme? |
|
Who was named?
- Pfizer 33 events
- Amgen 7 events
- HAYA Therapeutics
- Office for Attracting Strategic Enterprises (OASES)
- Jiangsu Hengrui Pharmaceuticals
More news naming Pfizer
- Sep 20 · Biotech Pfizer CEO says headwinds are easing 2
- Aug 25 · Healthcare Innovent announces 2026 interim results and 2030 strategic vision 2
- Aug 2 · Biotech CNBC: “AstraZeneca in talks with Bristol Myers Squibb on $400 billion megadeal, FT reports” 6
- Jul 20 · Biotech Study links several hormonal contraceptives to meningioma risk 3
Sources: the outlets' reports linked on this page; counts and times from GetYourBrief's record of those reports (methodology).